An analysis of 35 clinical trials found that treatment to reduce LDL cholesterol did not lower the risk of death in over three-quarters of the trials, neither did it lower the risk of heart disease in nearly half of the trials. — TNS
Setting targets for “bad” (low density lipoprotein, LDL) cholesterol levels to ward off heart disease and death in those at risk might seem intuitive.
But decades of research have failed to show any consistent benefit for this approach, reveals an analysis of the available data, published online in the BMJ Evidence Based Medicine journal.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
